Tracking in-situ checkpoint inhibitor bound target T cells in checkpoint colitis : Additional Data
Published: 17 April 2024| Version 1 | DOI: 10.17632/7z8yx644hb.1
Contributors:
Tarun Gupta, , , , , , , , , , , , , , , , , , , , , , , , , , , , Description
Additional Tables and Data for "Tracking in-situ checkpoint inhibitor bound target T cells in checkpoint colitis" by Gupta et al. Patients with Checkpoint inhibitor-induced colitis (CPI_colitis), Checkpoint inhibitor treatment without colitis (CPI_control), Ulcerative colitis (UC_I/UC) and Healthy Controls (HC) investigated with single-cell RNA sequencing and spatial transcriptomics
Files
Institutions
Weatherall Institute of Molecular Medicine, University of Oxford Oxford Translational Gastroenterology Unit, University of Oxford
Categories
Inflammatory Bowel Disease, Ulcerative Colitis, Immunotherapy, Immunohistochemistry, Immune Checkpoint Blockade, Single-Cell RNA Sequencing, Immune Checkpoint Inhibitor, Immunofluorescence, Spatial Transcriptomics